• By ICR Secretariat
  • Posted Monday, June 27, 2022

NICE recommends Eli Lilly’s breast cancer therapy

https://www.pharmatimes.com/news/nice_recommends_eli_lillys_breast_cancer_therapy_1450121

Verzenios in combination with endocrine treats people with early breast cancer who are at high-risk of recurrence